Related Experiment Videos
[Glucagon secretion in hyperlipoproteinemia and adiposity]
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|April 15, 1982
Summary
Patients with hyperlipoproteinemia and normal glucose tolerance show normal pancreatic A-cell sensitivity to glucose. Glucagon secretion disturbances are linked to diabetes mellitus, not hyperlipoproteinemia itself.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Research
Background:
- Hyperlipoproteinemia is associated with metabolic dysregulation.
- Understanding the interplay between lipid metabolism and glucose homeostasis is crucial.
- Pancreatic hormone secretion plays a key role in metabolic control.
Purpose of the Study:
- To investigate pancreatic A-cell sensitivity to glucose in hyperlipoproteinemia patients with normal glucose tolerance.
- To determine if glucagon secretion disturbances are characteristic of hyperlipoproteinemia or diabetes mellitus.
- To analyze the bihormonal (insulin-glucagon) relationship in obese individuals with normal glucose tolerance.
Main Methods:
- Examination of A-cell sensitivity to glucose.
- Assessment of pancreatic glucagon secretion.
- Bihormonal analysis (insulin-glucagon) following glucose or amino acid stimulation.
Main Results:
- Normal A-cell sensitivity to glucose observed in hyperlipoproteinemia patients with normal glucose tolerance.
- Glucagon secretion disturbances were primarily associated with the co-occurrence of hyperlipoproteinemia and diabetes mellitus.
- Obese individuals with normal glucose tolerance exhibited an anabolic state, suggesting potential for fat accumulation.
Conclusions:
- Hyperlipoproteinemia alone, in the absence of diabetes, does not appear to impair glucose-mediated A-cell function.
- Glucagon secretion abnormalities are more indicative of diabetes mellitus than hyperlipoproteinemia.
- The bihormonal profile in obese individuals suggests a metabolic state favoring fat storage.